Low-Dose Methotrexate Toxicity in a Hemodialysis Patient: A Case Report

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Turkish Journal of Internal Medicine
Volume:4 - Supplement 1 Special Issue
Low-Dose Methotrexate Toxicity in a Hemodialysis Patient: A Case Report

Low-Dose Methotrexate Toxicity in a Hemodialysis Patient: A Case Report

Authors : Mehmet SEZEN, Tuğçe YÜKSEL, Mehmet Refik GÖKTUĞ, Abdülmecit YILDIZ

Pages : 175-177

Doi:10.46310/tjim.1073681

View : 25 | Download : 22

Publication Date : 2022-04-01

Article Type : Other Papers

Abstract :Methotrexate insert ignore into journalissuearticles values(MTX); is an effective drug used to treat various diseases, especially rheumatological diseases. However, myelosuppression is a severe side effect, the frequency of which increases in patients with renal insufficiency. Here, we presented a chronic hemodialysis patient who developed pancytopenia and mucositis after using low-dose MTX to treat psoriasis.
Keywords : Methotrexate Toxicity, Hemodialysis, psoriasis

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.